EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urinary mutagenicity and bladder cancer risk in northern New England

Jason Y Y Wong iD, Alexander H Fischer, Dalsu Baris, Laura E Beane Freeman, Margaret R Karagas, Molly Schwenn, Alison Johnson, Peggy P Matthews, Adam E Swank, G Monawar Hosain, Stella Koutros, Debra T Silverman und 2 weitere

Environmental and Molecular Mutagenesis · 2024

DOI: 10.1002/em.22588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2024. Verfasst von Jason Y Y Wong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Community Health Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Mutagens, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS, NCI NIH HHS, Division of Cancer Epidemiology and Genetics, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The etiology of bladder cancer among never smokers without occupational or environmental exposure to established urothelial carcinogens remains unclear. Urinary mutagenicity is an integrative measure that reflects recent exposure to genotoxic agents. Here, we investigated its potential association with bladder cancer in rural northern New England. We analyzed 156 bladder cancer cases and 247 cancer‐free controls from a large population‐based case–control study conducted in Maine, New Hampshire, and Vermont. Overnight urine samples were deconjugated enzymatically and the extracted organics were assessed for mutagenicity using the plate‐incorporation Ames assay with the Salmonella frameshift strain YG1041 + S9. Logistic regression was used to estimate the odds ratios (OR) and 95% confidence intervals (CI) of bladder cancer in relation to having mutagenic versus nonmutagenic urine, adjusted for age, sex, and state, and stratified by smoking status (never, former, and current). We found evidence for an association between having mutagenic urine and increased bladder cancer risk among never smokers (OR = 3.8, 95% CI: 1.3–11.2) but not among former or current smokers. Risk could not be estimated among current smokers because nearly all cases and controls had mutagenic urine. Urinary mutagenicity among never‐smoking controls could not be explained by recent exposure to established occupational and environmental mutagenic bladder carcinogens evaluated in our study. Our findings suggest that among never smokers, urinary mutagenicity potentially reflects genotoxic exposure profiles relevant to bladder carcinogenesis. Future studies are needed to replicate our findings and identify compounds and their sources that influence bladder cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutagensUrinary Bladder NeoplasmsHumansUrinary BladderCase-Control StudiesNew EnglandCarcinogensMutagenicity Tests

Stichwörter der Autor:innen

bladdercancermutagenicitysmokingurine

Substanzen

MutagensCarcinogens

Autor:innen und Institutionen

  • Epidemiology and Community Health Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
  • Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
  • Maine Cancer Registry, Augusta, Maine, USA.
  • Vermont Cancer Registry, Burlington, Vermont, USA.
  • Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA.

ORCID-Profile: Jason Y Y Wong, David M DeMarini

Förderung

  • Intramural NIH HHS
  • NCI NIH HHS
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute

Zitieren

APA

Wong, J. Y. Y., Fischer, A. H., Baris, D., Beane Freeman, L. E., Karagas, M. R., Schwenn, M., Johnson, A., Matthews, P. P., Swank, A. E., Hosain, G. M., Koutros, S., Silverman, D. T., DeMarini, D. M., & Rothman, N. (2024). Urinary mutagenicity and bladder cancer risk in northern New England. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.22588

Vancouver

Wong JYY, Fischer AH, Baris D, Beane Freeman LE, Karagas MR, Schwenn M, et al. Urinary mutagenicity and bladder cancer risk in northern New England. Environmental and Molecular Mutagenesis. 2024. doi:10.1002/em.22588

BibTeX
@article{Wong2024,
  author = {Wong, Jason Y Y and Fischer, Alexander H and Baris, Dalsu and Beane Freeman, Laura E and Karagas, Margaret R and Schwenn, Molly and Johnson, Alison and Matthews, Peggy P and Swank, Adam E and Hosain, G Monawar and Koutros, Stella and Silverman, Debra T and DeMarini, David M and Rothman, Nathaniel},
  title = {Urinary mutagenicity and bladder cancer risk in northern New England},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2024},
  doi = {10.1002/em.22588}
}
Kostenlos starten →